A study of the safety and efficacy of ABH001 in the treatment of patients with epidermolysis bullosa who have wounds that are not healing.

Registry ID

EUCTR2012-001815-21

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE3

Sponsor

Shire Regenerative Medicine, Inc.

Start date

2013-05-21

Completion date

2013-10-02

Last update

2026-08-16

Conditions

• Epidermolysis bullosa

Summary

To evaluate the efficacy of ABH001 in initiating healing of selected cutaneous, stalled wounds in epidermolysis bullosa patients.

Locations

• , , Spain
• , , Germany
• , , Austria
• , , Portugal

Related clinical trials

• Social Participation of Patients with Epidermolysis Bullosa
• Changes in the Socio-economic Burden of Epidermolysis Bullosa in Europe
• Somatic mosaicism in skin fragility disorders: mechanisms and therapeutic perspectives

View on source registry